Watchlist Manager

Watchlist

Price: 2 456 JPY -0.57% Market Closed

Market Cap: ¥61.1B

	Fuji Pharma Co Ltd TSE:4554	JP

Income Statement

Currency: JPY

	Dec-2004	Mar-2005	Jun-2005	Dec-2005	Mar-2006	Jun-2006	Dec-2006	Mar-2007	Jun-2007	Dec-2007	Mar-2008	Jun-2008	Dec-2008	Mar-2009	Jun-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	4	5	6	5	5	5	12	30	44	55	59	53	48	50	48	44	42	37	35	41	35	35	41	29	34	34	30	37	38	38	36	37	39	41	43	40	39	37	35	37	37	53	68	79	82	77	78	85	99	107	123	138	165	196	232	255	0	0	0
Revenue	7 122 N/A	7 274 +2%	7 392 +2%	7 773 +5%	7 754 0%	8 145 +5%	8 750 +7%	9 291 +6%	9 861 +6%	10 211 +4%	10 291 +1%	10 598 +3%	10 567 0%	11 339 +7%	12 070 +6%	13 386 +11%	14 056 +5%	14 722 +5%	19 698 +34%	19 962 +1%	20 877 +5%	20 743 -1%	21 624 +4%	20 988 -3%	20 657 -2%	21 271 +3%	21 520 +1%	22 646 +5%	23 737 +5%	24 132 +2%	25 174 +4%	26 100 +4%	27 356 +5%	28 109 +3%	29 215 +4%	30 378 +4%	30 497 +0%	31 254 +2%	31 680 +1%	32 540 +3%	33 056 +2%	33 708 +2%	34 229 +2%	34 234 +0%	34 717 +1%	35 217 +1%	35 387 +0%	36 412 +3%	36 024 -1%	37 243 +3%	37 909 +2%	38 231 +1%	38 431 +1%	37 361 -3%	36 279 -3%	34 968 -4%	34 701 -1%	33 854 -2%	33 793 0%	34 120 +1%	34 165 +0%	34 392 +1%	33 990 -1%	34 141 +0%	34 439 +1%	34 962 +2%	35 426 +1%	35 976 +2%	36 925 +3%	38 438 +4%	40 889 +6%	41 639 +2%	43 052 +3%	44 562 +4%	46 138 +4%	48 392 +5%	48 845 +1%	49 937 +2%	51 677 +3%	54 574 +6%
Gross Profit
Cost of Revenue	(4 014)	(4 100)	(4 139)	(4 338)	(4 394)	(4 688)	(5 038)	(5 217)	(5 433)	(5 602)	(5 758)	(6 068)	(6 106)	(6 438)	(6 742)	(7 380)	(7 620)	(7 988)	(10 664)	(10 716)	(11 240)	(10 898)	(11 374)	(11 065)	(11 089)	(11 849)	(12 249)	(12 785)	(13 444)	(13 646)	(14 233)	(14 871)	(15 607)	(16 127)	(16 835)	(17 752)	(17 748)	(18 190)	(18 709)	(19 308)	(19 755)	(20 283)	(20 691)	(20 500)	(20 795)	(20 821)	(20 671)	(20 807)	(20 524)	(21 465)	(21 959)	(22 362)	(22 478)	(21 365)	(20 483)	(19 605)	(19 177)	(19 017)	(18 921)	(19 280)	(19 279)	(19 370)	(19 239)	(19 420)	(19 676)	(20 186)	(20 867)	(21 388)	(22 418)	(23 505)	(24 374)	(25 605)	(25 927)	(27 060)	(28 294)	(28 796)	(29 345)	(29 854)	(30 914)	(32 297)
Gross Profit	3 107 N/A	3 174 +2%	3 254 +3%	3 436 +6%	3 361 -2%	3 458 +3%	3 713 +7%	4 076 +10%	4 428 +9%	4 609 +4%	4 532 -2%	4 529 0%	4 460 -2%	4 900 +10%	5 328 +9%	6 006 +13%	6 436 +7%	6 734 +5%	9 034 +34%	9 245 +2%	9 635 +4%	9 843 +2%	10 250 +4%	9 922 -3%	9 568 -4%	9 422 -2%	9 272 -2%	9 861 +6%	10 293 +4%	10 486 +2%	10 941 +4%	11 229 +3%	11 749 +5%	11 982 +2%	12 380 +3%	12 626 +2%	12 749 +1%	13 064 +2%	12 971 -1%	13 232 +2%	13 301 +1%	13 425 +1%	13 538 +1%	13 734 +1%	13 922 +1%	14 396 +3%	14 716 +2%	15 605 +6%	15 500 -1%	15 778 +2%	15 950 +1%	15 869 -1%	15 953 +1%	15 996 +0%	15 796 -1%	15 363 -3%	15 524 +1%	14 837 -4%	14 872 +0%	14 840 0%	14 886 +0%	15 022 +1%	14 751 -2%	14 721 0%	14 763 +0%	14 776 +0%	14 559 -1%	14 588 +0%	14 507 -1%	14 933 +3%	16 515 +11%	16 034 -3%	17 125 +7%	17 502 +2%	17 844 +2%	19 596 +10%	19 500 0%	20 083 +3%	20 763 +3%	22 277 +7%
Operating Income
Operating Expenses	(2 673)	(2 623)	(2 702)	(2 276)	(2 295)	(2 371)	(2 557)	(2 650)	(2 816)	(2 854)	(2 940)	(3 089)	(3 284)	(3 585)	(3 836)	(4 061)	(4 220)	(4 251)	(5 802)	(6 003)	(6 331)	(6 508)	(6 684)	(6 852)	(6 716)	(6 736)	(6 525)	(6 718)	(6 911)	(7 238)	(7 680)	(8 038)	(8 536)	(8 720)	(9 207)	(9 463)	(9 697)	(9 892)	(9 720)	(9 966)	(9 671)	(9 534)	(9 970)	(9 726)	(9 899)	(10 120)	(10 402)	(10 840)	(11 185)	(11 478)	(11 559)	(11 598)	(11 370)	(11 426)	(11 623)	(11 742)	(12 083)	(12 167)	(11 733)	(11 056)	(10 796)	(10 506)	(11 402)	(11 508)	(11 388)	(11 415)	(10 782)	(11 183)	(11 618)	(12 365)	(12 657)	(13 506)	(13 648)	(13 832)	(13 964)	(14 324)	(14 758)	(15 051)	(15 773)	(15 753)
Selling, General & Administrative	(2 678)	(2 622)	(2 697)	(2 263)	(1 997)	(2 365)	(2 560)	(2 604)	(2 815)	(2 853)	(3 014)	(3 088)	(3 282)	(3 847)	(3 835)	(4 060)	(4 220)	(4 250)	(4 366)	(5 645)	(5 563)	(5 740)	(4 840)	(5 690)	(5 963)	(5 984)	(4 892)	(6 716)	(6 911)	(7 237)	(5 937)	(7 997)	(8 535)	(8 719)	(6 774)	(9 462)	(9 697)	(9 890)	(7 227)	(9 964)	(9 668)	(9 532)	(7 416)	(9 725)	(9 897)	(10 120)	(7 859)	(10 839)	(11 186)	(11 477)	(9 054)	(11 598)	(11 369)	(11 427)	(8 957)	(11 741)	(12 082)	(12 165)	(8 048)	(11 055)	(10 795)	(10 505)	(8 340)	(11 508)	(11 388)	(11 415)	(7 355)	(11 182)	(11 617)	(12 365)	(8 331)	(13 505)	(13 646)	(13 829)	(9 231)	(14 322)	(14 758)	(15 052)	(10 957)	(15 754)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 114)	(360)	(769)	0	(1 516)	0	0	0	(1 304)	0	0	0	(1 280)	0	0	0	(1 769)	0	0	0	(1 729)	0	0	0	(1 840)	0	0	0	(1 825)	0	0	0	(1 760)	0	0	0	(2 052)	0	0	0	(3 060)	0	0	0	(2 446)	0	0	0	(2 485)	0	0	0	(3 184)	0	0	0	(3 401)	0	0	0	(3 344)	0
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(321)	0	0	(1)	(325)	(1)	(1)	0	(331)	0	0	0	(462)	0	0	0	(663)	0	0	0	(762)	0	0	0	(713)	0	0	0	(717)	0	0	0	(745)	0	0	0	(613)	0	0	0	(624)	0	0	0	(616)	0	0	0	(941)	0	0	0	(1 141)	0	0	0	(1 331)	0	0	0	(1 472)	0
Other Operating Expenses	5	0	(5)	(13)	(298)	(7)	2	(46)	0	0	74	0	0	262	0	0	0	0	0	0	0	(767)	(2)	(1 161)	(752)	(752)	2	(1)	(1)	0	(1)	(41)	(1)	0	(1)	(1)	0	(2)	(2)	(2)	(3)	(2)	(1)	(1)	(2)	0	(1)	(1)	1	(1)	0	0	(1)	1	(1)	(1)	0	0	(1)	(1)	(1)	(1)	0	0	0	0	(1)	(1)	(1)	0	(1)	(1)	(2)	(3)	(1)	(2)	0	1	0	1
Operating Income	434 N/A	551 +27%	552 +0%	1 160 +110%	1 066 -8%	1 086 +2%	1 156 +6%	1 425 +23%	1 613 +13%	1 755 +9%	1 593 -9%	1 441 -10%	1 177 -18%	1 317 +12%	1 493 +13%	1 946 +30%	2 216 +14%	2 484 +12%	3 233 +30%	3 244 +0%	3 307 +2%	3 337 +1%	3 565 +7%	3 072 -14%	2 853 -7%	2 687 -6%	2 747 +2%	3 143 +14%	3 382 +8%	3 248 -4%	3 261 +0%	3 191 -2%	3 213 +1%	3 262 +2%	3 173 -3%	3 163 0%	3 052 -4%	3 172 +4%	3 251 +2%	3 266 +0%	3 630 +11%	3 891 +7%	3 568 -8%	4 008 +12%	4 023 +0%	4 276 +6%	4 314 +1%	4 765 +10%	4 315 -9%	4 300 0%	4 391 +2%	4 271 -3%	4 583 +7%	4 570 0%	4 173 -9%	3 621 -13%	3 441 -5%	2 670 -22%	3 139 +18%	3 784 +21%	4 090 +8%	4 516 +10%	3 349 -26%	3 213 -4%	3 375 +5%	3 361 0%	3 777 +12%	3 405 -10%	2 889 -15%	2 568 -11%	3 858 +50%	2 528 -34%	3 477 +38%	3 670 +6%	3 880 +6%	5 272 +36%	4 742 -10%	5 032 +6%	4 990 -1%	6 524 +31%
Pre-Tax Income
Interest Income Expense	0	0	0	0	0	0	0	0	0	0	0	0	1	2	3	3	3	3	5	1	(1)	0	(1)	(1)	0	(3)	(68)	105	100	81	61	31	5	19	(28)	(87)	(55)	(78)	(170)	(28)	(123)	(267)	(308)	(57)	48	219	305	107	64	(13)	(13)	(164)	(117)	(94)	(143)	(13)	(188)	(83)	(167)	(16)	174	75	60	(111)	(29)	79	193	133	(12)	(70)	97	3 097	3 086	3 033	2 996	(123)	(190)	(244)	(295)	(371)
Non-Reccuring Items	0	0	(12)	(30)	(37)	(99)	(82)	(103)	(103)	(108)	(74)	(13)	(14)	(6)	6	9	(25)	(37)	(87)	(95)	(89)	(84)	(42)	(395)	(382)	(373)	(365)	0	0	(46)	(43)	0	(7)	38	33	34	10	11	5	5	(116)	(116)	(122)	(122)	(10)	(11)	(98)	(98)	(101)	(100)	(5)	(5)	(4)	(20)	(212)	(212)	(1 397)	(209)	(69)	(69)	1 097	(75)	(34)	(34)	(14)	(14)	(288)	282	487	177	244	880	1 235	1 567	1 344	573	(627)	(685)	(780)	(3 428)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(6)	0	(10)	(14)	(8)	0	0	0	0	0	0	0	1	0	0	0	0	0	(13)	(13)	(18)	(18)	(5)	(5)	0	2	3	3	5	3	3	3	4	4	3	7	4	0	4	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	23	26	13	26	26	19	6	7	4	(2)	4	5	10	7	9	9	4	6	6	6	11	9	(20)	(22)	(18)	(13)	20	(54)	(34)	(22)	53	49	49	42	53	61	52	38	19	(136)	(158)	(143)	28	10	26	20	9	60	75	77	94	72	146	152	139	115	26	18	11	18	0	(1)	(6)	(2)	32	33	41	(99)	(50)	(37)	200	171	172	207	56	70	75	53	85	99
Pre-Tax Income	457 N/A	577 +26%	553 -4%	1 156 +109%	1 055 -9%	1 006 -5%	1 079 +7%	1 329 +23%	1 513 +14%	1 645 +9%	1 523 -7%	1 433 -6%	1 175 -18%	1 320 +12%	1 512 +15%	1 967 +30%	2 197 +12%	2 454 +12%	3 156 +29%	3 156 N/A	3 226 +2%	3 261 +1%	3 497 +7%	2 654 -24%	2 444 -8%	2 285 -7%	2 326 +2%	3 194 +37%	3 448 +8%	3 261 -5%	3 332 +2%	3 271 -2%	3 260 0%	3 361 +3%	3 232 -4%	3 171 -2%	3 059 -4%	3 143 +3%	3 105 -1%	3 107 +0%	3 220 +4%	3 352 +4%	3 148 -6%	3 821 +21%	4 082 +7%	4 499 +10%	4 530 +1%	4 836 +7%	4 356 -10%	4 267 -2%	4 472 +5%	4 177 -7%	4 611 +10%	4 611 N/A	3 961 -14%	3 515 -11%	1 885 -46%	2 403 +27%	2 918 +21%	3 717 +27%	5 366 +44%	4 516 -16%	3 371 -25%	3 067 -9%	3 365 +10%	3 460 +3%	3 723 +8%	3 721 0%	3 314 -11%	2 638 -20%	4 399 +67%	6 676 +52%	7 970 +19%	8 477 +6%	8 276 -2%	5 792 -30%	4 000 -31%	4 156 +4%	4 000 -4%	2 824 -29%
Net Income
Tax Provision	(149)	(212)	(188)	(446)	(390)	(376)	(388)	(534)	(614)	(653)	(579)	(544)	(467)	(523)	(591)	(762)	(853)	(969)	(1 212)	(1 221)	(1 213)	(1 200)	(1 292)	(1 029)	(966)	(891)	(955)	(1 192)	(1 302)	(1 256)	(1 264)	(1 273)	(1 277)	(1 267)	(1 153)	(1 119)	(1 112)	(1 112)	(1 012)	(985)	(925)	(997)	(1 029)	(1 169)	(1 247)	(1 357)	(1 228)	(1 310)	(1 099)	(1 047)	(1 099)	(1 010)	(1 286)	(1 323)	(998)	(902)	(307)	(396)	(832)	(1 048)	(1 569)	(1 354)	(938)	(844)	(1 119)	(1 026)	(1 026)	(1 028)	(679)	(601)	(963)	(1 615)	(2 050)	(2 114)	(2 128)	(1 393)	(822)	(1 087)	(1 000)	(491)
Income from Continuing Operations	308	365	365	710	665	630	692	796	901	993	945	889	708	798	923	1 208	1 347	1 487	1 944	1 936	2 013	2 061	2 205	1 625	1 478	1 394	1 371	2 001	2 145	2 004	2 068	1 998	1 983	2 094	2 079	2 052	1 947	2 031	2 093	2 122	2 295	2 355	2 119	2 652	2 835	3 142	3 302	3 526	3 257	3 220	3 373	3 167	3 325	3 288	2 963	2 613	1 578	2 007	2 086	2 669	3 797	3 162	2 433	2 223	2 246	2 434	2 697	2 693	2 635	2 037	3 436	5 061	5 920	6 363	6 148	4 399	3 178	3 069	3 000	2 333
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	308 N/A	365 +19%	365 N/A	710 +95%	665 -6%	630 -5%	692 +10%	796 +15%	901 +13%	993 +10%	945 -5%	889 -6%	708 -20%	798 +13%	923 +16%	1 208 +31%	1 347 +12%	1 487 +10%	1 944 +31%	1 936 0%	2 013 +4%	2 061 +2%	2 205 +7%	1 625 -26%	1 478 -9%	1 394 -6%	1 371 -2%	2 000 +46%	2 145 +7%	2 003 -7%	2 068 +3%	1 999 -3%	1 982 -1%	2 094 +6%	2 078 -1%	2 051 -1%	1 947 -5%	2 030 +4%	2 092 +3%	2 121 +1%	2 293 +8%	2 354 +3%	2 118 -10%	2 650 +25%	2 835 +7%	3 141 +11%	3 301 +5%	3 525 +7%	3 255 -8%	3 219 -1%	3 372 +5%	3 167 -6%	3 324 +5%	3 287 -1%	2 962 -10%	2 611 -12%	1 577 -40%	2 006 +27%	2 085 +4%	2 668 +28%	3 796 +42%	3 161 -17%	2 432 -23%	2 222 -9%	2 245 +1%	2 433 +8%	2 696 +11%	2 692 0%	2 634 -2%	2 036 -23%	3 435 +69%	5 060 +47%	5 920 +17%	6 363 +7%	6 146 -3%	4 398 -28%	3 176 -28%	3 066 -3%	3 000 -2%	2 333 -22%
EPS (Diluted)	12.83 N/A	15.2 +18%	15.2 N/A	29.58 +95%	27.7 -6%	24.23 -13%	26.61 +10%	30.61 +15%	34.65 +13%	38.19 +10%	36.34 -5%	34.19 -6%	27.23 -20%	30.69 +13%	35.5 +16%	46.46 +31%	51.8 +11%	57.19 +10%	74.76 +31%	74.46 0%	77.42 +4%	79.26 +2%	84.8 +7%	58.03 -32%	52.78 -9%	49.78 -6%	48.96 -2%	71.42 +46%	76.6 +7%	71.53 -7%	73.85 +3%	71.39 -3%	70.78 -1%	67.54 -5%	69.26 +3%	66.16 -4%	62.8 -5%	67.66 +8%	68.77 +2%	70.7 +3%	76.43 +8%	78.46 +3%	70.8 -10%	88.33 +25%	94.5 +7%	104.7 +11%	110.3 +5%	117.5 +7%	108.5 -8%	107.3 -1%	112.67 +5%	105.83 -6%	111.05 +5%	105.69 -5%	97.02 -8%	83.81 -14%	50.61 -40%	64.39 +27%	66.92 +4%	85.63 +28%	136.73 +60%	130.14 -5%	90.52 -30%	91.48 +1%	92.41 +1%	100.15 +8%	110.98 +11%	110.81 0%	108.38 -2%	83.79 -23%	141.35 +69%	208.19 +47%	243.57 +17%	261.71 +7%	252.81 -3%	180.81 -28%	130.08 -28%	125.51 -4%	122.93 -2%	95.39 -22%

Income Statement Balance Sheet Cash Flow Statement

Fuji Pharma Co Ltd
TSE:4554

Income Statement

Earnings Waterfall
Fuji Pharma Co Ltd

Income Statement
Fuji Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Fuji Pharma Co Ltd TSE:4554

Income Statement

Earnings Waterfall Fuji Pharma Co Ltd

Income Statement Fuji Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Fuji Pharma Co Ltd
TSE:4554

Earnings Waterfall
Fuji Pharma Co Ltd

Income Statement
Fuji Pharma Co Ltd